AU2001228488A1 - Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels - Google Patents
Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channelsInfo
- Publication number
- AU2001228488A1 AU2001228488A1 AU2001228488A AU2848801A AU2001228488A1 AU 2001228488 A1 AU2001228488 A1 AU 2001228488A1 AU 2001228488 A AU2001228488 A AU 2001228488A AU 2848801 A AU2848801 A AU 2848801A AU 2001228488 A1 AU2001228488 A1 AU 2001228488A1
- Authority
- AU
- Australia
- Prior art keywords
- modulate
- activity
- hyperpolarisation
- cation channels
- identifying substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
The present invention provides a process for identifying substances that modulate the activity of hyperpolarization-activated cation channels, and the use of this process.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10006309A DE10006309A1 (en) | 2000-02-12 | 2000-02-12 | Method for the identification of substances that modulate the activity of hyperpolarization-activated cation channels |
DE10006309 | 2000-02-12 | ||
PCT/EP2001/000755 WO2001059153A2 (en) | 2000-02-12 | 2001-01-24 | Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001228488A1 true AU2001228488A1 (en) | 2001-08-20 |
Family
ID=7630723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001228488A Abandoned AU2001228488A1 (en) | 2000-02-12 | 2001-01-24 | Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels |
Country Status (9)
Country | Link |
---|---|
US (2) | US6979532B2 (en) |
EP (1) | EP1257819B1 (en) |
JP (1) | JP4782967B2 (en) |
AT (1) | ATE403864T1 (en) |
AU (1) | AU2001228488A1 (en) |
DE (2) | DE10006309A1 (en) |
DK (1) | DK1257819T3 (en) |
ES (1) | ES2311529T3 (en) |
WO (1) | WO2001059153A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002098287A2 (en) * | 2001-06-06 | 2002-12-12 | The Trustees Of Columbia University In The City Of New York | A high throughput biological heart rate monitor that is molecularly determined |
US20050002914A1 (en) * | 2003-01-15 | 2005-01-06 | Rosen Michael R. | Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
US7794702B2 (en) * | 2003-01-15 | 2010-09-14 | The Trustees Of Columbia University In The City Of New York | Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
GB0303506D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
US8859273B2 (en) * | 2003-12-24 | 2014-10-14 | Medtronic, Inc. | Methods of using HCN genes to treat cardiac arrhythmias |
US20090029366A1 (en) * | 2007-03-28 | 2009-01-29 | Wyeth | Methods of identifying modulators of hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
CN102762746B (en) | 2010-02-23 | 2015-04-29 | 克里斯托弗·戈登·阿特伍德 | Methods for the detection of biologically relevant molecules and their interaction characteristics |
US8734780B2 (en) * | 2010-06-04 | 2014-05-27 | Medtronic, Inc. | Methods for treating cardiac pacing conditions |
US8899504B2 (en) | 2011-11-30 | 2014-12-02 | Whirlpool Corporation | Externally-operated adjustment mechanism for a food processing device |
US8905342B2 (en) | 2011-11-30 | 2014-12-09 | Whirlpool Corporation | Food processing device with lid mounted adjustment mechanism |
US8814072B2 (en) | 2011-11-30 | 2014-08-26 | Whirlpool Corporation | User-controlled adjustment mechanism for a food processing device |
US8833683B2 (en) | 2012-03-08 | 2014-09-16 | Whirlpool Corporation | Food processor with external control for operating an adjustable cutting tool |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0684993A1 (en) * | 1993-02-19 | 1995-12-06 | PHARMACIA & UPJOHN COMPANY | Human dna sequence encoding a kidney atp-dependent potassium channel |
DE19621312A1 (en) * | 1996-05-28 | 1997-12-04 | Bayer Ag | Masking of background fluorescence and signal amplification in the optical analysis of biological medical assays |
GB9718365D0 (en) * | 1997-08-29 | 1997-11-05 | Univ London | Ion channel proteins |
US6703485B2 (en) | 1997-12-23 | 2004-03-09 | The Trustees Of Columbia University In The City Of New York | Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof |
DE19806581A1 (en) | 1998-02-17 | 1999-10-21 | Forschungszentrum Juelich Gmbh | Ih ion channel sequences and their use |
AU4456800A (en) * | 1999-04-15 | 2000-11-02 | Icagen, Inc. | Human hac3 |
AU4980200A (en) * | 1999-05-27 | 2000-12-18 | Pharmacia & Upjohn Company | Methods and compositions for measuring ion channel conductance |
US20090029366A1 (en) * | 2007-03-28 | 2009-01-29 | Wyeth | Methods of identifying modulators of hyperpolarization-activated cyclic nucleotide-gated (hcn) channels |
-
2000
- 2000-02-12 DE DE10006309A patent/DE10006309A1/en not_active Ceased
-
2001
- 2001-01-24 DK DK01951152T patent/DK1257819T3/en active
- 2001-01-24 WO PCT/EP2001/000755 patent/WO2001059153A2/en active IP Right Grant
- 2001-01-24 DE DE50114193T patent/DE50114193D1/en not_active Expired - Lifetime
- 2001-01-24 JP JP2001558489A patent/JP4782967B2/en not_active Expired - Fee Related
- 2001-01-24 ES ES01951152T patent/ES2311529T3/en not_active Expired - Lifetime
- 2001-01-24 EP EP01951152A patent/EP1257819B1/en not_active Expired - Lifetime
- 2001-01-24 AU AU2001228488A patent/AU2001228488A1/en not_active Abandoned
- 2001-01-24 AT AT01951152T patent/ATE403864T1/en not_active IP Right Cessation
-
2002
- 2002-02-07 US US10/067,457 patent/US6979532B2/en not_active Expired - Lifetime
-
2005
- 2005-03-24 US US11/088,356 patent/US7550257B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2311529T3 (en) | 2009-02-16 |
WO2001059153A3 (en) | 2002-04-11 |
US20070231849A1 (en) | 2007-10-04 |
US7550257B2 (en) | 2009-06-23 |
EP1257819A2 (en) | 2002-11-20 |
DK1257819T3 (en) | 2009-01-19 |
ATE403864T1 (en) | 2008-08-15 |
DE10006309A1 (en) | 2001-08-23 |
US20030082513A1 (en) | 2003-05-01 |
WO2001059153A2 (en) | 2001-08-16 |
US6979532B2 (en) | 2005-12-27 |
JP4782967B2 (en) | 2011-09-28 |
EP1257819B1 (en) | 2008-08-06 |
DE50114193D1 (en) | 2008-09-18 |
JP2003522533A (en) | 2003-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002365508A1 (en) | Apparatus and method for modification of magnetically immobilized biomolecules | |
AU2002345497A1 (en) | Cips as modifiers of the p53 pathway and method of use | |
WO2003002717A3 (en) | Biological activity of ak155 | |
AU2002318477A1 (en) | Method and apparatus for peer-to-peer services | |
WO1999054286A3 (en) | Btk inhibitors and methods for their identification and use | |
WO2002074293A3 (en) | Methods for restoring cognitive function following systemic stress | |
AU2001228488A1 (en) | Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels | |
IN2014DN05011A (en) | ||
AU2003300817A1 (en) | Modulating immune responses | |
MY125565A (en) | Intermediates and process for preparing olanzapine | |
WO1999025843A3 (en) | Human checkpoint kinase, hcds1, compositions and methods | |
NZ320259A (en) | Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors | |
DE69712878D1 (en) | Phosphatasemodulator | |
AU2001266070A1 (en) | Method for identifying apoptosis-modified proteins | |
CA2349529A1 (en) | Pge synthase and methods and means for modulating its activity | |
WO2002055725A3 (en) | Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production | |
AR027327A1 (en) | PROCEDURE FOR THE EINZYMATIC SEPARATION OF AMINOMETIL-ARIL-CICLOHEZANOL DERIVATIVES | |
AU2003211040A1 (en) | The eaat2 promoter and uses thereof | |
MXPA04010915A (en) | Dynamic human resources knowledge base and process. | |
MXPA01008214A (en) | Inhibitors of separin, method for identifying them and uses. | |
WO2001012838A3 (en) | Compounds which modulate the activity of an lpa receptor | |
AU2002326018A1 (en) | Assay for identifying ion channel modulators | |
AU1653100A (en) | Use of diminazene-di-aceturate for treating malaria | |
AU2002251873A1 (en) | Methods and compositions for modulating gluconeogenesis using pgc-1 | |
WO2001020335A3 (en) | Methods for modulating cell proliferation |